Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 63629-4597

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 63629-4597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem 01

FDA Label Image

Zolpidem 02

Zolpidem 02
This is a chart representing Zolpidem plasma concentrations (measured in ng/mL) over time after taking either 12.5mg of Zolpidem tartrate extended-release or 10mg of Zolpidem tartrate immediate-release. The x-axis shows the time in hours and the y-axis represents the concentration of Zolpidem in the plasma. This chart can be useful to understand the drug's pharmacokinetics and optimize dosing for individuals.*
FDA Label Image

Lbl636294597

Lbl636294597
This appears to be a label from a medication package. It includes the name of the person who packaged it (Bryant Ranck), the medication name (possibly a generic version of Ambien CR 12.5mg), the manufacturer (Lek Pharmaceuticals), quantity (30 tablets), and an expiration date (MM/YY). The label also includes a National Drug Code (NDC) and storage instructions. There is a warning to keep drugs out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.